Prognostic Value of Estimated Plasma Volume in Heart Failure

JACC: Heart Failure

Volumn 3, Issue 11, 2015, Pages 886-893

  Duarte, Kévin ^a,b,c   Monnez, Jean Marie ^a,b,c   Albuisson, Eliane ^a,b,d,e   Pitt, Bertram ^f   Zannad, Faiez ^a,d,e,g,h   Rossignol, Patrick ^a,e,g,h  

^a UNIVERSITÉ DE LORRAINE   (France)

^b CNRS   (France)

^c INRIA   (France)

^d UNIVERSITY HOSPITAL OF NANCY   (France)

^e INSERM   (France)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^g INSERM UMR S 1116 University of Lorraine   (France)

^h F CRIN INI CRCT (Cardiovascular and Renal Clinical Trialists)   (France)

Author keywords

congestion; heart failure; plasma volume

Indexed keywords

HEMOGLOBIN;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; BODY WEIGHT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CLINICAL OUTCOME; CONTROLLED STUDY; ESTIMATED GLOMERULAR FILTRATION RATE; ESTIMATED PLASMA VOLUME; ESTIMATED PLASMA VOLUME VARIATION; FEMALE; GENERAL PATHOLOGICAL PARAMETERS; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMATOCRIT; HEMODYNAMICS; HOSPITALIZATION; HUMAN; KIDNEY; KILLIP CLASS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEW YORK HEART ASSOCIATION CLASS; PLASMA VOLUME; POST HOC ANALYSIS; PREDICTION; PREDICTIVE VALUE; PREDICTOR VARIABLE; PROGNOSTIC VALUE; METABOLISM; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ADULT; AGED; FEMALE; HEART FAILURE; HEMATOCRIT; HEMOGLOBINS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLASMA VOLUME; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84984817999     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.06.014     Document Type: Article

References (25)

1. Gheorghiade, M., Follath, F., Ponikowski, P., et al. Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12 (2010), 423–433.
2. Miller, W.L., Mullan, B.P., Understanding the heterogeneity in volume overload and fluid distribution in decompensated heart failure is key to optimal volume management: role for blood volume quantitation. J Am Coll Cardiol HF 2 (2014), 298–305.
3. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62 (2013), e147–239.
4. Testani, J.M., Chen, J., McCauley, B.D., Kimmel, S.E., Shannon, R.P., Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 122 (2010), 265–272.
5. Rossignol, P., Ménard, J., Fay, R., Gustafsson, F., Pitt, B., Zannad, F., Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects: insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy. J Am Coll Cardiol 58 (2011), 1958–1966.
6. van der Meer, P., Postmus, D., Ponikowski, P., et al. The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure. J Am Coll Cardiol 61 (2013), 1973–1981.
7. Greene, S.J., Gheorghiade, M., Vaduganathan, M., et al., for the EVEREST Trial Investigators. Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail 15 (2013), 1401–1411.
8. Testani, J.M., Brisco, M.A., Chen, J., McCauley, B.D., Parikh, C.R., Tang, W.H., Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 62 (2013), 516–524.
9. Pitt, B., Remme, W., Zannad, F., et al., for the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. [published correction appears in N Engl J Med 2003;348:2271] N Engl J Med 348 (2003), 1309–1321.
10. Strauss, M.B., Davis, R.K., Rosenbaum, J.D., Rossmeisl, E.C., Water diuresis produced during recumbency by the intravenous infusion of isotonic saline solution. J Clin Invest 30 (1951), 862–868.
11. Kalra, P.R., Anagnostopoulos, C., Bolger, A.P., Coats, A.J., Anker, S.D., The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol 39 (2002), 1901–1908.
12. Dill, D.B., Costill, D.L., Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37 (1974), 247–248.
13. Kaplan, A.A., A simple and accurate method for prescribing plasma exchange. ASAIO Trans 36 (1990), M597–M599.
14. Ismail, N., Neyra, R., Hakim, R.M., Plasmapheresis. Daugirdis, J.T., Blake, P.G., Ing, T.S., (eds.) Handbook of dialysis, 3rd edition, 2001, Lippincott Williams & Wilkins, Philadelphia, 231–262.
15. Levey, A.S., Coresh, J., Balk, E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. [published correction appears in Ann Intern Med 2003;139:605] Ann Intern Med 139 (2003), 137–147.
16. McMurray, J.J., Adamopoulos, S., Anker, S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association (HFA) of the ESC. [published correction appears in Eur Heart J 2013;15:361–2] Eur Heart J 14 (2012), 803–869.
17. Mentz, R.J., Kjeldsen, K., Rossi, G.P., et al. Decongestion in acute heart failure. Eur J Heart Fail 16 (2014), 471–482.
18. Davenport, A., Anker, S.D., Mebazaa, A., et al., and the Acute Dialysis Quality Initiative (ADQI) Consensus Group. ADQI 7: the clinical management of the cardio-renal syndromes: work group statements from the 7th ADQI consensus conference. Nephrol Dial Transplant 25 (2010), 2077–2089.
19. Boyle, A., Sobotka, P.A., Redefining the therapeutic objective in decompensated heart failure: hemoconcentration as a surrogate for plasma refill rate. J Card Fail 12 (2006), 247–249.
20. Anker, S.D., Ponikowski, P., Varney, S., et al. Wasting as independent risk factor for mortality in chronic heart failure. [published correction appears in Lancet 1997;349:1258] Lancet 349 (1997), 1050–1053.
21. Anker, S.D., Negassa, A., Coats, A.J., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361 (2003), 1077–1083.
22. Pocock, S.J., McMurray, J.J., Dobson, J., et al. Weight loss and mortality risk in patients with chronic heart failure in the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Programme. Eur Heart J 29 (2008), 2641–2650.
23. Buffaloe, G.W., Heineken, F.G., Plasma volume nomograms for use in therapeutic plasma exchange. Transfusion 23 (1983), 355–357.
24. Sprenger, K.B., Huber, K., Kratz, W., Henze, E., Nomograms for the prediction of patient's plasma volume in plasma exchange therapy from height, weight, and hematocrit. J Clin Apher 3 (1987), 185–190.
25. Marenzi, G., Lauri, G., Grazi, M., Assanelli, E., Campodonico, J., Agostoni, P., Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38 (2001), 963–968.